GlassScriptPhysician profile
Kyle Robert Rasmussen
NPI 1457995177
$6,260.36
in general payments reported to CMS, 2019-2025
45 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,477 · 2022: $1,099 · 2023: $1,278 · 2024: $1,343 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,546 · Travel and Lodging: $119 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,545.94 |
| Travel and Lodging | $118.75 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,228.81 | 2021-2025 | |
| Novo Nordisk INC | $1,034.54 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $467.27 | 2022-2025 | |
| Amgen INC. | $446.04 | 2021-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $441.81 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $254.87 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $254.50 | 2021-2025 | Trintellix |
| Daiichi Sankyo INC. | $224.22 | 2021-2024 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $158.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.22 | 2021-2025 | Jardiance, Tradjenta |
| Biohaven Pharmaceutical Holding Company LTD. | $130.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $119.72 | 2021-2023 | Xarelto |
| Shockwave Medical, INC | $118.75 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $116.25 | 2021-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
| Glaxosmithkline, LLC. | $115.18 | 2021-2025 | Arexvy, Shingrix |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $81.29 | 2023-2025 | Watchman Flx, Watchman |
| Shield Therapeutics INC | $70.02 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $67.83 | 2024-2025 | Opsumit, Uptravi |
| Exact Sciences Corporation | $62.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corium, LLC | $58.08 | 2023 | Azstarys |
| Novartis Pharmaceuticals Corporation | $54.80 | 2021-2024 | |
| Baxter Healthcare | $44.07 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Dexcom, INC. | $43.03 | 2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $40.24 | 2021 | |
| Phathom Pharmaceuticals, INC. | $39.62 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $38.08 | 2022 | |
| Seqirus USA INC | $37.81 | 2025 | Flucelvax, Fluad |
| Otsuka America Pharmaceutical, INC. | $37.09 | 2021-2024 | Rexulti |
| Horizon Therapeutics Plc | $36.43 | 2023 | Krystexxa |
| Astellas Pharma US INC | $23.24 | 2024 | Veozah |
| Esperion Therapeutics, INC. | $22.61 | 2021 | |
| Sumitomo Pharma America, INC. | $22.23 | 2025 | Gemtesa |
| Philips North America LLC | $21.81 | 2024 | (Ck6) Holter |
| Lundbeck LLC | $21.80 | 2023 | Vyepti |
| Idorsia Pharmaceuticals US INC | $20.46 | 2023 | Quviviq |
| Ultragenyx Pharmaceutical INC. | $19.07 | 2022 | |
| Antares Pharma, INC. | $17.63 | 2024 | Xyosted |
| Xeris Pharmaceuticals, INC. | $17.24 | 2025 | Gvoke Hypopen |
| Edwards Lifesciences Corporation | $17.00 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Gilead Sciences, INC. | $16.67 | 2021 | |
| Medtronic, INC. | $16.14 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.80 | 2025 | Unithroid |
| Insulet Corporation | $14.45 | 2021 | |
| Watermark Medical, INC. | $13.17 | 2024 | |
| Jazz Pharmaceuticals INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.